About the company
Takeda Pharmaceutical, founded in 1781, has continuously evolved and thrived over centuries to become a global leader in the pharmaceutical industry. With a rich history and a commitment to improving patient lives, the company has emerged as a powerhouse in the field. One of Takeda's key strengths lies in its diverse portfolio of products, which align with five core therapeutic areas. Oncology, one of the most critical sectors in healthcare, is one of Takeda's main focuses. The company develops innovative treatments for various types of cancers, aiming to improve patients' survival rates and quality of life. In addition to oncology, Takeda places significant emphasis on gastroenterology, addressing disorders and diseases that affect the digestive system. Through extensive research and development, the company aims to provide effective treatments for conditions like Crohn's disease, ulcerative colitis, and acid reflux, among others. Takeda also invests heavily in neuroscience, recognizing the growing prevalence of neurodegenerative disorders and mental health conditions worldwide. The company is dedicated to finding breakthrough solutions for conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia, and depression. Rare diseases, often overlooked due to their low prevalence, are another crucial area of focus for Takeda. The company works tirelessly to develop therapies for individuals affected by rare genetic disorders, aiming to improve their quality of life and offer hope where few treatment options exist. Furthermore, Takeda is a leader in plasma-derived therapies, harnessing the power of donated plasma to create life-saving treatments for patients with immunodeficiencies, bleeding disorders, and other conditions. These therapies, derived from human plasma, provide vital support to individuals in need, illustrating the company's commitment to meeting critical unmet medical needs. Takeda's geographic footprint is strategically diverse, enabling the company to leverage various markets' opportunities and resources. The United States, the largest pharmaceutical market globally, forms the backbone of its operations, driving 50% of its revenue. Takeda's strong presence in the U.S. allows it to tap into a vast customer base, innovate, and deliver breakthrough therapies to patients across the country. Japan, Takeda's home market, contributes 20% of its revenue. As a Japanese company deeply rooted in its homeland, Takeda is committed to bringing forth advancements in healthcare to benefit the local population. Its strong presence in Japan allows the company to meet the unique healthcare needs of its citizens and contribute to the country's health ecosystem. Europe and Canada account for another 20% of Takeda's revenue. With a significant presence in these markets, the company enjoys access to diverse patient populations, healthcare systems, and research collaborations. This enables Takeda to develop localized solutions and cater to the specific needs of these regions, further cementing its global leadership. As Takeda continues to expand and evolve, it remains dedicated to its mission of striving for a healthier future for patients worldwide. With its robust portfolio, diverse geographic presence, and unwavering commitment to innovation, Takeda Pharmaceutical is well-positioned to shape the future of the pharmaceutical industry and make a lasting impact on patient care.
Website: https://www.takeda.com
Data updated: June 2, 2026
